iShares US Healthcare ETF holds a quantitatively derived Bronze Morningstar Medalist Rating. The rating reflects that it has scored better than the norm on factors Morningstar research associates with future outperformance relative to category peers.
iShares U.S. Healthcare ETF IYH
Morningstar’s Analysis IYH
Will IYH outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
The People Pillar is our evaluation of the IYH management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of IYH’s parent organization’s priorities and whether they’re in line with investors’ interests.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 58.5
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Eli Lilly and Co | 15.66 | 465M | Healthcare |
Johnson & Johnson | 9.74 | 289M | Healthcare |
AbbVie Inc | 6.97 | 207M | Healthcare |
UnitedHealth Group Inc | 6.22 | 185M | Healthcare |
Merck & Co Inc | 5.17 | 153M | Healthcare |
Amgen Inc | 3.30 | 98M | Healthcare |
Thermo Fisher Scientific Inc | 3.24 | 96M | Healthcare |
Gilead Sciences Inc | 2.91 | 86M | Healthcare |
Abbott Laboratories | 2.73 | 81M | Healthcare |
Pfizer Inc | 2.61 | 77M | Healthcare |
United States